河化股份(000953) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 was ¥37,976,698.50, a decrease of 5.29% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥5,731,820.08, representing a significant decline of 1,452.50% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥5,795,516.42, a decrease of 11,086.85% compared to the previous year[5]. - Total operating revenue for the period was CNY 131,888,715.06, a decrease of 1.1% compared to CNY 133,381,231.81 in the previous period[18]. - Net profit for the third quarter was a loss of ¥4,041,708.17, compared to a profit of ¥3,866,625.39 in the same period last year, indicating a significant decline[20]. - Operating profit turned negative at ¥-4,024,899.09, down from ¥4,721,083.41 in the previous year[19]. - The company reported a total comprehensive income of ¥-4,041,708.17, compared to ¥3,866,625.39 in the previous year[20]. - Basic and diluted earnings per share were both ¥-0.0112, compared to ¥0.0090 in the same quarter last year[20]. Assets and Liabilities - The total assets at the end of the reporting period were ¥372,353,452.42, down 6.07% from the end of the previous year[5]. - Total assets decreased to CNY 372,353,452.42 from CNY 396,411,315.40, reflecting a decline of 6.1%[16]. - Total liabilities decreased to CNY 181,618,317.70 from CNY 202,272,965.76, a reduction of 10.2%[16]. - The company’s non-current assets increased slightly to CNY 246,701,910.38 from CNY 241,285,798.75, an increase of 2.4%[15]. - The company’s retained earnings showed a slight decline, with a balance of CNY -710,612,948.36 compared to CNY -706,515,946.95 in the previous period[16]. Cash Flow - The cash flow from operating activities for the year-to-date was ¥3,538,796.92, a decrease of 55.69% compared to the same period last year[5]. - Cash flow from operating activities generated ¥3,538,796.92, a decrease of 55.7% compared to ¥7,985,606.47 in the prior year[21]. - Cash flow from investment activities yielded a net inflow of ¥24,919,237.25, up from ¥6,443,147.62 year-over-year[22]. - The company’s cash and cash equivalents at the end of the period totaled ¥64,153,407.11, down from ¥68,159,883.04 at the end of the previous year[22]. - Cash and cash equivalents increased to CNY 64,153,407.11 from CNY 35,685,903.67, representing an increase of 79.5%[15]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 23,695[10]. - The largest shareholder, Ningbo Yinyi Holdings Co., Ltd., held 23.76% of the shares, with 87,000,000 shares pledged[10]. Research and Development - The company's R&D expenses decreased by 46.19% year-on-year to ¥3,087,644.84, due to optimization of the R&D personnel structure[9]. - Research and development expenses decreased to ¥3,087,644.84 from ¥5,738,149.25, reflecting a reduction of approximately 46%[19]. Inventory and Operating Costs - The company's inventory increased by 45.05% to ¥34,548,875.93, primarily due to an increase in stock of finished goods[9]. - Inventory rose to CNY 34,548,875.93, up from CNY 23,818,434.02, indicating a growth of 45.2%[15]. - Total operating costs increased to ¥142,417,525.67 from ¥131,518,124.41, representing an increase of approximately 8.4% year-over-year[19]. Legal and Investment Activities - The company won a lawsuit against Alkaloida Chemical Company, receiving a total of USD 673,500 in goods and USD 271,401.39 in penalties[12]. - The company plans to invest CNY 44,519,300 in the technical transformation of production lines and multi-functional pilot workshops[13]. Credit Impairment - The company incurred a credit impairment loss of ¥5,165,633.90, significantly higher than ¥669,137.58 in the same period last year[19].